Home LiteratureArticle Details
PMID: 6250070 Published · ppublish English Journal Article

DNA cloning in Streptomyces: resistance genes from antibiotic-producing species.

Nature ·Vol. 286 ·No. 5772 ·1980-07-31 ·Pages 525-7

Thompson CJ, Ward JM, Hopwood DA

Abstract

The biochemical and morphological differentiation of actinomycetes makes them academically and economically interesting. Their secondary metabolites provide the majority of medically and agriculturally important antibiotics (streptomycete genes may also be the primary source of clinically important antibiotic resistance); their complex morphological developmental cycle involves a series of changes from vegetative mycelial growth to spore formation. Recombinant DNA technology would add a powerful new dimension to the analysis of these various aspects of actinomycete biology and would also facilitate the development of industrial strains with increased antibiotic yield, or capable of making new antibiotics. For most of these purposes, cloning of genes within and between actinomycetes is required to study the expression of particular genes in genetic backgrounds defined by mutations of the characters under study. To achieve this, we have now developed a method for molecular cloning involving the transfer of genes between unrelated streptomycetes.

MeSH Terms
Cloning, Molecular/methods DNA Restriction Enzymes Drug Resistance, Microbial Plasmids R Factors Streptomyces/genetics
Chemicals
DNA Restriction Enzymes
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Thompson C J
Ward J M
Hopwood D A
Article Info
Journal
Nature
Abbr.
Nature
ISSN
0028-0836
Published
1980-07-31
Pages
525-7
Language
English
Region
England
NLM ID
0410462
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com